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ABSTRACT
The CRISPR/Cas adaptive immune system provides
resistance against phages and plasmids in Archaea
and Bacteria. CRISPR loci integrate short DNA
sequences from invading genetic elements that
provide small RNA-mediated interference in sub-
sequent exposure to matching nucleic acids. In
Streptococcus thermophilus, it was previously
shown that the CRISPR1/Cas system can provide
adaptive immunity against phages and plasmids
by integrating novel spacers following exposure
to these foreign genetic elements that subse-
quently direct the specific cleavage of invasive
homologous DNA sequences. Here, we show that
the S. thermophilus CRISPR3/Cas system can be
transferred into Escherichia coli and provide heter-
ologous protection against plasmid transformation
and phage infection. We show that interference
is sequence-specific, and that mutations in the
vicinity or within the proto-spacer adjacent motif
(PAM) allow plasmids to escape CRISPR-encoded
immunity. We also establish that cas9 is the sole
cas gene necessary for CRISPR-encoded interfer-
ence. Furthermore, mutation analysis revealed that
interference relies on the Cas9 McrA/HNH- and
RuvC/RNaseH-motifs. Altogether, our results show
that active CRISPR/Cas systems can be transferred
across distant genera and provide heterologous
interference against invasive nucleic acids. This
can be leveraged to develop strains more robust
against phage attack, and safer organisms less
likely to uptake and disseminate plasmid-encoded
undesirable genetic elements.
INTRODUCTION
Bacteria and Archaea rely on a diversity of defense
systems that allow them to survive exposure to foreign
genetic elements such as viruses. In their natural
habitats, bacteria have evolved a battery of defense mech-
anisms to prevent phage infection, including prevention
of adsorption, blocking of injection, or degradation of
foreign nucleic acids (1,2). Recently, an adaptive prokary-
otic immune system based on clustered regularly
interspaced short palindromic repeats (CRISPR) was
identiﬁed that provides acquired immunity against
viruses and plasmids (3). CRISPR consists of arrays of
short conserved repeat sequences interspaced by unique
DNA sequences of similar size called spacers, which
often originate from phage or plasmid DNA (3–5).
CRISPR arrays, together with cas (CRISPR-associated)
genes form the CRISPR/Cas adaptive immune system.
The CRISPR/Cas system has the ability to acquire
short pieces of DNA (spacers) which provide immunity
against subsequent exposures to phages and plasmids
that carry matching sequences (3,6,7). The detailed mech-
anism by which CRISPR/Cas systems provides resistance
against foreign DNA is subject to multiple current studies.
Although the large majority of bacteria die upon virulent
phage infection, a small proportion of the population
survives by acquisition of phage-derived spacers (3).
CRISPR-encoded immunity is provided by transcription
of the repeat-spacer array, followed by transcript process-
ing into small crRNAs (CRISPR RNAs), which are then
used in combination with Cas proteins as guides to
interfere with invasive DNA (6,7) or RNA (8).
Cas proteins, which often carry functional domains
typical of nucleases, helicases, polymerases and
nucleotide-binding proteins (9), are involved in multiple
stages of CRISPR-based immunity. Notwithstanding
their genetic hypervariability and mechanistic
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different subtypes (9,10).
A few model systems have been established in the study
of CRISPR/Cas functionality, notably in Escherichia coli
(6,11), Staphylococcus aureus (7), Pyrococcus furiosus (8)
and Streptococcus thermophilus (3,12). The S. thermophilus
DGCC7710 model organism, for which CRISPR/Cas
interference has been demonstrated against phages (3,13)
and plasmids (12) contains four distinct CRISPR/Cas
systems: CRISPR1, CRISPR2, CRISPR3 and CRISPR4
(14) (Figure 1). Direct spacer acquisition activity has
been demonstrated for the CRISPR1 and CRISPR3
systems, with the former being more active in this strain
(3,12,13). CRISPR1 and CRISPR3, which both belong to
Type II CRISPR/Cas systems (15), share a similar archi-
tecture, with four cas genes located upstream of the
CRISPR spacer array. Both cas1 and cas2 are universal,
whereas cas9 (formerly named cas5 and csn1) is the
signature gene of the Type II system. It has been shown
that cas9 and csn2 are involved in interference and spacer
acquisition, respectively (3,12). In silico analysis of phage
sequences adjacent to CRISPR1 and CRISPR3 proto-
spacers (nucleotide sequences in the target DNA cor-
responding to the spacers) revealed the presence of
conserved PAM (Proto-spacer Adjacent Motif) sequences,
NNAGAAW and NGGNG respectively (13,16,17), that
are involved in interference. Single point mutations in the
proto-spacer or the PAM allow the phages to circumvent
CRISPR-mediated immunity (13).
The CRISPR2 and CRISPR4 systems present in the
S. thermophilus DGCC7710 genome belong to the Type
III (Mtube) and Type I (Ecoli), respectively (14,15).
Differences between types can be observed in terms of
repeat, spacer and cas gene content and sequence. The
multiplicity of CRISPR/Cas systems in S. thermophilus
is explained by their susceptibility to horizontal gene
transfer, and phage selective pressure.
Here we report the ﬁrst cloning and heterologous
expression of a functional CRISPR/Cas system into a
different bacterial genus. We demonstrate that the
S. thermophilus CRISPR3 system prevents plasmid trans-
formation in E. coli. We show that both the proto-spacer
and PAM sequences are necessary for immunity, although
mutations distant from the PAM are tolerated.
Furthermore, we provide experimental evidence that
Cas9 alone is sufﬁcient for plasmid DNA interference,
and demonstrate by mutational analysis the importance
of the McrA/HNH- and RuvC/RNaseH- nuclease
domains.
MATERIALS AND METHODS
Bacterial strains and plasmids
Escherichia coli strain ER2267 [F0 proA
+B
+ lacI
q
(lacZ)M15 zzf::mini-Tn10 (Kan
R)/(argF-lacZ)U169
glnV44 e14
 (McrA
 ) rfbD1? recA1 relA1? endA1
spoT1? thi-1 (mcrC-mrr)114::IS10] (New England
Biolabs, Beverly, MA, USA) and E. coli strain RR1 [F-
mcrB mrr hsdS20(rB
  mB
 ) leuB6 ara-14 proA2 lacY1
galK2 xyl-5 mtl-1 rpsL20(Sm
R) glnV44  
 ] (18) were
used in the cloning and plasmid transformation experi-
ments, respectively. Escherichia coli cells were grown in
LB medium supplemented with ampicillin (50mg/ml) and/
or chloramphenicol (10mg/ml) when necessary. Plasmid
vectors pACYC184 (19) and pUC18 (20) were used for
cloning and subcloning procedures. Genomic DNA of
Streptococcus thermophilus DGCC7710 strain was kindly
provided by Danisco (Dange ´ -Saint-Romain, France).
Isolation of DNA and recombinant DNA techniques
Plasmids were isolated using GeneJET Plasmid Miniprep
Kit (Fermentas, Vilnius, Lithuania). Standard procedures
(21) were used for generation of recombinant plasmid.
The QIAquick Gel Extraction Kit (Qiagen, Chatsworth,
CA, USA) was used for isolation of DNA fragments from
agarose gels. DNA sequencing was carried out on an ABI
PRISM 377 sequencer by using The BigDye Terminator
v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster
City, CA, USA). All enzymes used for DNA manipula-
tions and corresponding buffers were obtained from
Fermentas.
Construction of plasmids
For construction of plasmids used in the transformation
assay, the pUC18 vector was cut with EcoRI and
dephosphorylated with FastAP
TM alkaline phosphatase,
oligoduplexes (Supplementary Table S1) containing
sticky EcoRI ends were assembled by annealing com-
plementary oligonucleotides (Metabion, Martinsried,
Germany), phosphorylated with T4 polynucleotide
kinase and ligated using T4 ligase.
Plasmid transformation
Transformations were performed using the CaCl2
heat-shock procedure (21). Escherichia coli RR1 strain,
carrying pCRISPR3 plasmid or its derivatives (see
sections below), was used as a recipient strain. Cells
were grown in LB medium at 37 C until OD600=0.4.
One milliliter aliquot of bacterial culture was used for
each transformation experiment which was performed at
0 C. Cells were recovered by centrifugation, washed
using 0.5ml of ‘Na solution’ [5mM Tris–HCl (pH 8.0),
100mM NaCl and 5mM MgCl2) and resuspended into
Figure 1. CRISPR/Cas systems of S. thermophilus DGCC7710. Cas
proteins of the CRISPR1 and CRISPR3 systems belong to Type II,
while CRISPR2 and CRISPR4 belong to Type III and Type I,
respectively.
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CaCl2, 5mM MgCl2] and incubated for 20min. After
incubation, cells were centrifugated, and pellets were
resuspended into 50ml ‘Ca solution’ at 0 C. One
nanogram of plasmid DNA was added to competent
E. coli cells, incubated for 20min at 4 C followed by
2min incubation at 42 C. Then 450ml of LB medium
were added to the transformation mix and incubated at
37 C for 1h. Finally, transformants were plated on LB
agar with appropriate antibiotics. All transformation ex-
periments were repeated at least three times. Bars in the
graphs are presented as mean values from three or more
independent experiments±1 SD.
Frameshift mutations/deletions of cas genes
To inactivate cas genes, frameshift mutations or small
deletions were created. The pCas9(–) plasmid was con-
structed by cutting pCRISPR3 with Eco105I–Bpu1102I.
The inactivation of cas1, cas2 and csn2 genes was per-
formed in two steps. First, the blunt-ended Eco31I–NheI
DNA fragment from pCRISPR3, which encodes all three
genes, was subcloned into HindIII-EcoRI pre-cleaved and
blunt-ended pUC18 vector. The resulting plasmid
pUC-CRISPR3del was used for subsequent inactivation
of cas genes. For cas1 inactivation, pUC-CRISPR3del
was cleaved with Eco72I–Eco47III and re-ligated with
T4 DNA ligase to generate the recombinant pUCcas1
plasmid which has a 41-bp deletion. For cas2 gene
inactivation, pUC-CRISPR3del was cleaved with XagI,
blunt-ended and re-ligated to generate the recombinant
plasmid pUCcas2 which has a 1-bp insertion leading
to a frameshift mutation in cas2. For the csn2 gene inacti-
vation, the pUC-CRISPR3 plasmid was cut with EcoRI,
blunt-ended and re-ligated to generate the pUCcsn2
plasmid which has a 4-bp insertion in csn2 gene.
Mutated genes in all three cases were transferred into
the pCRISPR3 plasmid by subcloning BstXI–Eco147I
DNA fragments from pUCcas1, pUCcas2, and
pUCcsn2 plasmids. Recombinant plasmids were called
pCas1(–), pCas2(–) and pCsn2(–), respectively. To obtain
pCas9 plasmid lacking cas1, cas2 and csn2 genes, ﬁrst
the Eco47III–BcuI deletion in pUC-CRISPR3 was
obtained and then the BstXI-Eco147I DNA fragment
from pUC[cas1 csn2] plasmid was subcloned into
pCRISPR3 plasmid to yield pCas9 plasmid.
Site-directed mutagenesis
Megaprimer method (22) was used to obtain plasmids
carrying a mutated cas9 gene (see ‘Materials and
methods’ section in Supplementary Data for the details).
RESULTS
Cloning of the CRISPR3/Cas system in E. coli
The S. thermophilus DGCC7710 CRISPR3/Cas locus
(GenBank HQ712120) spans  7.6kb and consists of
four cas genes: cas9, cas1, cas2 and csn2, followed by an
A+T rich 382-bp leader sequence and an array of
13 repeat-spacer units (Figure 2A). In order to clone the
CRISPR3/Cas locus in E. coli, we used three different
primer pairs to generate three DNA fragments covering
the  7.6-kb CRISPR3/Cas locus (Supplementary
Figure S1). These fragments were cloned separately
into the pACYC184 plasmid, and reassembled into
a full-length CRISPR3/Cas locus using two
Figure 2. CRISPR3/Cas system of S. thermophilus provides immunity against plasmid transformation in E. coli cells. (A) Schematic representation of
CRISPR3/Cas system cloning and construction of the plasmids for interference assay. Streptococcus thermophilus CRISPR3/Cas system was cloned
into E. coli plasmid pACYC184. Plasmids for interference assays were obtained by inserting a proto-spacer and PAM into pUC18 plasmid.
(B) Schematic representation of the plasmid transformation interference assay. Escherichiacoli RR1 recipient strains carrying plasmids pCRISPR3
and pACYC184 with and without the S. thermophilus CRISPR3/Cas system, respectively, were transformed with plasmids pSP1 and pSP2 carrying
proto-spacers and PAMs or pUC18. (C) Interference of plasmid transformation by S. thermophilus CRISPR3/Cas system in E. coli cells.
Transformation efﬁciency is expressed as cfu per nanogram of plasmid DNA (mean±SD).
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(Figure 2A), the  7.6-kb fragment containing the
natural S. thermophilus promoter and other possible regu-
latory elements located upstream of Cas9, is inserted
487bp downstream of the constitutive tet gene promoter
(Ptet). It remains to be established whether the components
of the recombinant interference system are expressed from
Ptet or from the native CRISPR/Cas promoters.
The CRISPR3/Cas system prevents plasmid
transformation in E. coli
To test the functional activity of the CRISPR3 system in
the heterologous E. coli host, we used a plasmid DNA
transformation assay (see ‘Materials and methods’
section). Using pUC18, which is compatible with
pACYC184 in E. coli, we engineered pSP1 and pSP2
(Figure 2), which contained proto-spacer sequences
identical to spacers SP1 and SP2 in the CRISPR3
array, together with the corresponding PAM
50-TGGTG-30 downstream of the proto-spacer sequence
(Supplementary Table S1), and tested the plasmid trans-
formation efﬁciency in recipient E. coli cells carrying either
pCRISPR3 or pACYC184 (Figure 2B). Typically, 1ng of
plasmid DNA per milliliter of E. coli bacterial culture in
LB medium (OD600=0.4) was used for transformation.
When the recipient strain carrying pACYC184 plasmid
was transformed using pSP1, pSP2 or pUC18, the
number of transformants exceeded 10
3 colony forming
units (cfu) (Figure 2C). However, when the recipient
strain carrying the pCRISPR3 plasmid was transformed
with the same set of plasmids, no colony was obtained for
the pSP1 and pSP2 plasmids (Figure 2C), but the control
plasmid (pUC18), which lacks a proto-spacer, yielded
10
3 cfu. This is consistent with the presence of
CRISPR-encoded speciﬁc immunity against spacers SP1
and SP2 in the pCRISPR3 plasmid. Interestingly, pUC18
contains 95 additional 50-GGTG-30 sequences correspond-
ing to the PAM of the CRISPR3 system but no corres-
ponding proto-spacer sequences. This is consistent with
the necessity to have both a proto-spacer and an adjoining
PAM in order for CRISPR-encoded immunity to occur.
Altogether these results indicate that the heterologous
plasmid pCRISPR3 interferes with transformation of
pSP1 and pSP2 plasmids, both bearing corresponding
proto-spacer and PAMs, but not with the control
pUC18 plasmid. When a recipient strain carrying
plasmid pACYC184 is used, no interference with
plasmid transformation is observed.
To estimate the efﬁciency of plasmid transformation, we
performed similar experiments using 100ng of plasmids.
Again, in the recipient strain carrying pCRISPR3, no
colony was obtained but >10
5 cfu of transformants were
obtained with the control vector (pUC18). The same
number of transformants was obtained when the recipient
strain containing pACYC184 was transformed with
100ng of pSP1. This means that CRISPR3/Cas system
in E. coli reduces the efﬁciency of plasmid transformation
with more than ﬁve orders of magnitude. This is quanti-
tatively comparable to the level of phage interference
previously established in S. thermophilus, where
CRISPR-based immunity reduces phage-sensitivity and
efﬁciency of plaquing by four to ﬁve orders of magnitude
per spacer (3,13). These results indicate that CRISPR/Cas
systems can be transferred between distant bacterial
genera and used heterologously to provide immunity
against plasmids.
The CRISPR3/Cas system provides resistance against
phage lambda in E. coli
In order to investigate the interference scope of the heter-
ologous S. thermophilus CRISPR3/Cas system in E. coli,
we assessed whether it could provide resistance against
phages in addition to interference against plasmids. We
inserted in vitro a spacer (anti- vir) targeting a lambda
phage sequence adjacent to the corresponding PAM (16)
into the heterologous CRISPR3 locus on the pCRISPR3
plasmid (Supplementary Figure S4) and subsequently
tested whether the engineered CRISPR system could
confer resistance against phage lambda (see ‘Materials
and methods’ section in Supplementary Data). Results
showed that E. coli cells containing the CRISPR3/Cas
system with the anti- vir spacer were less sensitive to
phage lambda by approximately three orders of magni-
tude, in comparison to the control cells that carried a
wild-type CRISPR3 locus without the anti- vir spacer
(Supplementary Figure S5). These preliminary results
indicate that the heterologous CRISPR3/Cas system can
also provide immunity against phages in E. coli, and sets
the stage for further studies that will assess the interference
potential of heterologous CRISPR/Cas systems.
Position-dependent tolerance for mismatches in
CRISPR-based plasmid interference
Phage challenge assays in S. thermophilus DGCC7710
have revealed that to ensure phage interference, 100%
identity between the spacer sequence from the CRISPR
array and the corresponding proto-spacer sequence in
the phage DNA is required (3,13). To assess whether
sequence identity between a spacer and the target
proto-spacer sequence is important for the efﬁciency of
plasmid transformation, we engineered plasmids
pSP1-sA2G, pSP1-sC11T, pSP1-sG18C, pSP1-sA23T,
pSP1-sA25T and pSP1-sA28T (Supplementary Table S1)
which carried single mutations at distinct positions across
the proto-spacer sequence (A2G, C11T, G18C, A23T,
A25T and A28T, respectively), and analyzed transform-
ation efﬁciency of the recipient strain containing
pCRISPR3 (Figure 3A). Consistent with the phage chal-
lenge assay, single point mutations A25T and A28T in the
proto-spacer abolished recipient strain ability to prevent
plasmid transformation. Unexpectedly, single mismatches
at the proto-spacer positions 2, 11, 18, 23 had no effect on
the recipient strain ability to interfere with plasmid trans-
formation (Figure 3A). Taken together our data suggest
that CRISPR3/Cas system tolerates single nucleotide
mismatches between spacer and proto-spacer at certain
positions. In light of recent results indicating that
cleavage of invading plasmid and phage DNA occurs
3-bp upstream of the PAM sequence in CRISPR1 (12),
and given the relatedness of CRISPR1 and CRISPR3
9278 Nucleic Acids Research, 2011,Vol.39, No. 21systems, it is likely that the mutations at positions 25 and
28 impact cleavage, whereas distal mutations would not.
The PAM sequence is important for plasmid interference
PAM sequences are of crucial importance for the phage
interference by the CRISPR1 system of S. thermophilus
(13,16). To test whether the PAM sequence is important
in prevention of plasmid DNA transformation by the
CRISPR3/Cas system, we engineered pSP1-p plasmid
so as to carry proto-spacer SP1 without its adjacent
PAM sequence. Transformation efﬁciency of E. coli re-
cipient cells with or without CRISPR3 system by the
pSP1-p plasmid was similar (Figure 3C). This indicates
that the PAM sequence is required for CRISPR3 interfer-
ence of plasmid transformation, and that the sole presence
of a proto-spacer is not sufﬁcient. To test whether all
three conserved residues of the predicted PAM sequence
50-NGGNG-30 are equally important, we constructed
plasmid variants pSP1-pG1C, pSP1-pG2C and
pSP1-pG4C (Supplementary Table S1) were three
guanine residues in the PAM sequence 50-GGTG-30 were
replaced by cytosine residues. Transformation experi-
ments revealed that E. coli cells containing pCRISPR3
or pACYCY184 plasmids were efﬁciently transformed
(10
3 cfu) by the plasmids containing single mutations in
the PAM region (Figure 3C). These data clearly demon-
strate that while CRISPR3/Cas system tolerates single
mutations at certain positions in the proto-spacer region,
a conserved PAM sequence is required for the plasmid
DNA interference in E. coli.
Only Cas9 is required for plasmid interference in E. coli
It was previously shown that inactivation of cas9 from the
CRISPR1 system in S. thermophilus resulted in the loss of
phage resistance, while inactivation of csn2 (cas7) did not
alter phage resistance but impaired the ability to incorp-
orate new spacers (3). To determine the role of individual
Cas proteins in the interference step, we engineered frame-
shift mutants of individual cas genes, generating plasmids
pCas9(–), pCas1(–), pCas2(–), pCsn2(–) (Figure 4A)
and monitored the efﬁciency of the pSP1 plasmid trans-
formation into corresponding recombinant E. coli recipi-
ent cells. Mutants lacking cas1, cas2 or csn2 retained
the ability to interfere with plasmid transformation
(Figure 4B). However, E. coli cells carrying pCas9(–)
plasmid with mutated cas9, were efﬁciently transformed
both by pSP1 and pUC18 plasmids. This is consistent
with previous results indicating that cas9 and csn2
are involved in interference and spacer acquisition,
respectively (3).
To further conﬁrm that Cas9 alone can provide inter-
ference with plasmid transformation, we deleted the three
other cas genes (cas1, cas2, csn2) in pCRISPR3 to
generate a pCas9 plasmid which contains only cas9, the
leader sequence, and a repeat-spacer region (Figure 4A).
The recipient strain containing pCas9 plasmid retained
the ability to interfere with pSP1 plasmid transformation
(Figure 4B), indicating that Cas9 is the only Cas protein
required to provide resistance against foreign DNA.
This suggests that Cas1, Cas2 and Csn2 might rather be
involved in novel spacer acquisition.
Figure 3. Impact of proto-spacer and PAM mutations on CRISPR-encoded plasmid immunity. (A) Effect of mutations in the proto-spacer region on
the plasmid transformation efﬁciency. Mutations are shown schematically above the ﬁgure. (B) Effect of mutations in the PAM region on the
plasmid transformation efﬁciency.
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Cas9 proteins are predicted to contain RuvC/RNaseH and
McrA/HNH signature motifs (9). The HNH motif is char-
acteristic of many nucleases that act on double-stranded
DNA including colicins (23,24), restriction enzymes (25)
and homing endonucleases (26). RuvC/RNaseH fold
includes proteins that show wide spectra of nucleolytic
functions, acting both on RNA and DNA (RNaseH,
RuvC, DNA transposases and retroviral integrases, and
PIWI domain of Argonaut proteins) (27). To test whether
the conserved amino-acid residues D31 (RuvC/RNaseH
motif) (Supplementary Figure S2), H865, N882 and
N891 (McrA/HNH motif) (Supplementary Figure S3)
are important for Cas9 function, alanine replacement
mutants were constructed in the pCas9 plasmid by site-
directed mutagenesis to generate recombinant plasmids
pD31A, pH868A, pN882A and pN891A, respectively.
Plasmid transformation assays revealed that all three
mutations in the HNH motif and a single mutation
in RuvC/RNaseH motif abolish the Cas9-dependent
plasmid interference (Figure 4D). Accordingly, the
amino-acid residues of the HNH motif and the conserved
aspartate in the N-terminal part of protein play anessential
role in the plasmid DNA interference by Cas9 in vivo.
DISCUSSION
The role of Cas proteins in the defense mechanism
CRISPR/Cas loci are highly diverse and fall within differ-
ent categories depending on the type, number of cas genes
and architecture of the cas operon (9,10). The diversity of
CRISPR/Cas systems implies mechanistic differences
which remain to be established. Meanwhile, two different
pathways which target invading genetic elements via the
crRNAs and act on DNA (6,7) or RNA (8) targets are
emerging. It was shown recently that the S. thermophilus
CRISPR1/Cas system speciﬁcally cleaves plasmid
and bacteriophage double-stranded DNA within the
proto-spacer in vivo, at speciﬁc sites (12). This endonucle-
ase activity seems to require Cas9 but it remains to be
established whether other Cas proteins of the CRISPR1/
Cas system contribute to the cleavage. The CRISPR3/Cas
system of S. thermophilus DGC7710 belongs to the same
Type II (Nmeni) group, and contains a similar set of cas
genes (Figure 1), suggesting that both systems may be
mechanistically similar. We show here that CRISPR3/
Cas module cloned into E. coli is functionally active and
provides host cell with interference against plasmid and
phage.
The S. thermophilus CRISPR3/Cas Cas9 is a large
protein comprised of 1388 amino acid residues. In silico
analysis identiﬁed a McrA/HNH-nuclease motif and
a RuvC/RNaseH-like nuclease signature in the Cas9
protein sequence (9,10). We provide experimental
evidence that the alanine replacement of the conserved
D31 (RNaseH/RuvC-motif), and H865, N882 and N891
(HNH-motif) residues abolishes Cas9-mediated plasmid
interference in E. coli. Since HNH-domains are often
found in nucleases that act on double-stranded DNA,
we suggest that the HNH-domain of Cas9 is involved in
the DNA degradation step. In the CRISPR1/Cas system,
Figure 4. Mutational analysis of cas genes. (A) Schematic representation of plasmids carrying mutant variants of cas genes. Individual genes were
disrupted by frameshift mutations or small deletions. Three cas genes (cas1, cas2, csn2) were removed by deletion. (B) cas9 gene alone prevents
plasmid DNA transformation. (C) Mutagenesis of Cas9 protein. Conserved domains and mutated amino acids are indicated. (D) Mutations in the
conserved RuvC/RNaseH  and McrA/HNH domains inactivate cas9.
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within the proto-spacer sequence (12). If Cas9 of the
CRISPR3/Cas system is a monomer in solution and
contains a single HNH-motif, it has to dimerise or
employ a second active site to cleave both DNA strands.
It is possible that HNH- and RuvC/RNaseH-like catalytic
sites may act on different DNA strands to achieve
a double strand break; a similar strategy is exploited
by some restriction endonucleases (28). The RuvC-like
nuclease domain is identiﬁed in proteins that act on
both DNA and RNA, including RNaseH, RuvC, and
PIWI domain of Argonaut proteins (27). Therefore, we
cannot exclude that the N-terminal RNaseH/RuvC
domain in Cas9 might be involved in crRNA maturation.
Studies of Cas9 nuclease and ribonuclease functions both
in vivo and in vitro are currently on-going.
Our studies of the S. thermophilus CRISPR3/Cas system
demonstrate that different CRISPR/Cas systems follow
different strategies to achieve cleavage of invading
DNA. Indeed, in contrast to a single S. thermophilus
Cas9 protein which is potentially involved in both
crRNA maturation and DNA cleavage steps, in E. coli a
large nucleic acid–protein complex which include crRNA,
Cascade and Cas3 is thought to be involved in the
degradation of foreign DNA (6).
‘Vaccination’ of E. coli against plasmids and phages by
the heterologous CRISPR3/Cas system
There is strong evidence suggesting that CRISPR/Cas
systems can move between distinct species in Bacteria
and Archaea via horizontal gene transfer (29–31). First,
CRISPR/Cas content of closely related species or strains
might differ, while on the other hand, evolutionary distant
species (even across Bacteria and Archaea) might harbor
similar CRISPR systems (10,29,32). For example, genome
sequencing of the three closely related S. thermophilus
strains revealed that CNRZ1066 and LMG18311 possess
two CRISPR/Cas systems (CRISPR1/Cas and CRISPR2/
Cas) (16), whereas the LMD-9 strain has an additional
Type II system, CRISPR3/Cas (16). Furthermore,
S. thermophilus DGCC7710 contains a fourth CRISPR/
Cas system (Figure 1) which belongs to Type I (14). It is
likely that in S. thermophilus the CRISPR4/Cas system
has been acquired recently by horizontal gene transfer,
especially since this species is naturally competent for
transformation (33). Secondly, there is often a codon
bias and/or a marked GC-content difference between
CRISPR/Cas loci and the rest of the chromosome (30).
In addition, mobile genetic elements such as insertion
sequences are usually located in the vicinity of CRISPR/
Cas systems, while some CRISPR/Cas systems are located
on large plasmids (>40kb) (29) and even prophages (34).
Here, we provide the ﬁrst experimental evidence
showing that the CRISPR3/Cas system of the Gram-
positive S. thermophilus species can be cloned into a
plasmid and transferred to a Gram-negative E. coli host.
Furthermore, we show that the heterologous system
provides resistance against incoming plasmids and
phages that carry matching proto-spacer sequences and
PAMs. This ﬁnding illustrates that CRISPR/Cas systems
may function as mobile gene cassettes that overcome
barriers between distant species such as incompatibility
of promoters and other regulation signals. This successful
transfer of a functional CRISPR/Cas system into a
phylogenetically distant host opens novel possibilities for
practical applications, notably the transfer of active
CRISPR/Cas systems between species in order to ‘vaccin-
ate’ bacteria against viruses or plasmids. In light of recent
results indicating that CRISPR-encoded immunity can
target antibiotic resistance genes (12), there is great
interest in transferring active CRISPR/Cas systems in
order to strengthen the immunity of select species or
strains against the uptake and dissemination of antibiotic
resistance genes.
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